MetLife Investment Management’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $242K | Sell |
|
|||||
|
2025
Q2 | $249K | Buy |
|
|||||
|
2025
Q1 | $272K | Sell |
|
|||||
|
2024
Q4 | $483K | Buy |
|
|||||
|
2024
Q3 | $389K | Hold |
|
|||||
|
2024
Q2 | $392K | Buy |
|
|||||
|
2024
Q1 | $423K | Hold |
|
|||||
|
2023
Q4 | $574K | Hold |
|
|||||
|
2023
Q3 | $348K | Hold |
|
|||||
|
2023
Q2 | $538K | Buy |
|
|||||
|
2023
Q1 | $561K | Hold |
|
|||||
|
2022
Q4 | $623K | Hold |
|
|||||
|
2022
Q3 | $898K | Hold |
|
|||||
|
2022
Q2 | $655K | Buy |
|
|||||
|
2022
Q1 | $590K | Buy |
|
|||||
|
2021
Q4 | $105K | Hold |
|
|||||
|
2021
Q3 | $138K | Buy |
|